CJC-1295 Safety Profile Differences in South Asian Patients
Evidence-based review of CJC-1295 (modified GRF 1-29) safety considerations for South Asian populations, including pharmacogenomic variation, cardiovascular risk at lower BMI thresholds, and clinical monitoring adjustments.
Read clinical review